Verrica Pharmaceuticals sell PlusUltra
Start price
12.12.20
/
50%
€8.75
Target price
12.12.21
-
Performance (%)
-2.29%
End price
13.12.21
€8.55
Summary
This prediction ended on 13.12.21 with a price of €8.55. With a performance of -2.29%, the SELL prediction by PlusUltra was trending in the right direction. PlusUltra has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Verrica Pharmaceuticals | 12.570% | 12.570% | 19.915% | -25.132% |
iShares Core DAX® | 4.015% | 2.971% | 16.492% | 19.144% |
iShares Nasdaq 100 | 2.755% | 0.503% | 40.029% | 50.636% |
iShares Nikkei 225® | -0.826% | -5.057% | 14.566% | 2.379% |
iShares S&P 500 | 2.330% | 0.720% | 30.194% | 44.181% |
According to PlusUltra what are the pros and cons of Verrica Pharmaceuticals for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Comments by PlusUltra for this prediction
In the thread Discuss Verrica Pharmaceuticals
Sell Verrica Pharmaceuticals
In the thread Trading Verrica Pharmaceuticals
Die von PlusUltra gewählte maximale Laufzeit wurde überschritten